Literature DB >> 36237286

Relationship between protein arginine methyltransferase and cardiovascular disease (Review).

Sisi Zheng1, Congcong Zeng1, Ailing Huang1, Fuqi Huang1, Anna Meng1, Zhuan Wu2, Shouhong Zhou1,3,4.   

Abstract

Protein arginine methyltransferases (PRMTs) are widely found in eukaryotes and regulate gene expression and post-translational modifications. PRMT1-PRMT6 have important roles in the pathology of cardiovascular diseases (CVDs), including atherosclerosis, heart failure and myocardial hypertrophy. Although these enzymes are also closely associated with various CVDs, the mechanisms of the involvement of PRMTs in the regulation of CVD have remained largely elusive. PRMTs methylate arginine residues and other factors. The present review describes the roles of PRMT1-PRMT6 in CVD. Furthermore, the biological characteristics of PRMTs and mechanisms by which PRMTs regulate cholesterol metabolism are being introduced. This review aims to provide inspiration for cardiovascular drug research and offer clues for research on the pathogenesis of CVD.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  atherosclerosis; cardiac hypertrophy; cholesterol metabolism; heart failure; protein arginine methyltransferase

Year:  2022        PMID: 36237286      PMCID: PMC9500492          DOI: 10.3892/br.2022.1572

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  70 in total

Review 1.  Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).

Authors:  Yalemi Morales; Tamar Cáceres; Kyle May; Joan M Hevel
Journal:  Arch Biochem Biophys       Date:  2015-12-02       Impact factor: 4.013

Review 2.  Dynamic RNA Modifications in Gene Expression Regulation.

Authors:  Ian A Roundtree; Molly E Evans; Tao Pan; Chuan He
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

3.  Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients.

Authors:  Ibrahim Dogan; Tolga Dogan; Mucahit Yetim; Huseyin Kayadibi; Mehmet B Yilmaz; Baris Eser; Macit Kalcik; Yusuf Karavelioglu
Journal:  Ther Apher Dial       Date:  2017-12-04       Impact factor: 1.762

4.  Identification of a degradation signal at the carboxy terminus of SREBP2: A new role for this domain in cholesterol homeostasis.

Authors:  Daniel L Kober; Shimeng Xu; Shili Li; Bilkish Bajaj; Guosheng Liang; Daniel M Rosenbaum; Arun Radhakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

Review 5.  Heart Failure in Older Adults.

Authors:  Hoda Butrous; Scott L Hummel
Journal:  Can J Cardiol       Date:  2016-05-10       Impact factor: 5.223

6.  Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl.

Authors:  Wenya Hou; Sabine Nemitz; Simone Schopper; Michael Lund Nielsen; Michael Manfred Kessels; Britta Qualmann
Journal:  Dev Cell       Date:  2018-04-23       Impact factor: 12.270

Review 7.  The emergence of protein arginine methyltransferases in skeletal muscle and metabolic disease.

Authors:  Tiffany L vanLieshout; Vladimir Ljubicic
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-10-08       Impact factor: 4.310

8.  PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation.

Authors:  Byeong-Yun Ahn; Myong-Ho Jeong; Jung-Hoon Pyun; Hyeon-Ju Jeong; Tuan Anh Vuong; Ju-Hyeon Bae; Subin An; Su Woo Kim; Yong Kee Kim; Dongryeol Ryu; Hyun-Ji Kim; Hana Cho; Gyu-Un Bae; Jong-Sun Kang
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

9.  Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease.

Authors:  Ayaka Ito; Cynthia Hong; Kazuhiro Oka; Jon V Salazar; Cody Diehl; Joseph L Witztum; Mercedes Diaz; Antonio Castrillo; Steven J Bensinger; Lawrence Chan; Peter Tontonoz
Journal:  Immunity       Date:  2016-12-20       Impact factor: 31.745

10.  LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2.

Authors:  Maryem A Hussein; Elina Shrestha; Mireille Ouimet; Tessa J Barrett; Sarah Leone; Kathryn J Moore; Yann Hérault; Edward A Fisher; Michael J Garabedian
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.